Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.

• For investors considering whether Corcept Therapeutics at around US$42.49 is priced attractively or already reflecting a lot of optimism, this article walks through key signals that can help frame that question.

• The stock has been volatile, with a 10.3% return over the last 7 days and 20.4% over the last 30 days. It is also sitting on an 11.2% return year to date and a 46.5% decline over the past year, alongside 90.6% and 85.5% returns over the last 3 and 5 years respectively.

• Recent headlines around Corcept Therapeutics have kept attention on the company and…